Ads
related to: pfeget.dtitrader.com has been visited by 10K+ users in the past month
wktrader.com has been visited by 10K+ users in the past month
Search results
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 11 hours agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 18 hours agoOne healthcare giant stands out In the defensive-oriented healthcare sector, one dividend stock stands out from the crowd: Pfizer (NYSE: PFE). The pharma...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Pfizer rolls out another cost-cutting program, sets $1.5 bln target by 2027
Reuters· 10 hours ago, opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 9 hours agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 2 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we detected 13 trades ...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 7 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 1 day agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 3 days agoIn the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction, Gottlieb Scott now holds 9,000 shares worth roughly $0.26 million. Argus downgraded its Pfizer ...
